Re: Neuroendocrine differentiation markers guide treatment sequence selection in metastatic castration‐resistant prostate cancer. The Prostate. 2019;1–7-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Re: Neuroendocrine differentiation markers guide treatment sequence selection in metastatic castration‐resistant prostate cancer. The Prostate. 2019;1–7

Published:2019-02-27 Issue:7 Volume:79 Page:813-814
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23775

Reference18 articles.

1. Neuroendocrine differentiation in carcinomas of the prostate: Do neuroendocrine serum markers reflect immunohistochemical findings?

2. Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival

3. Chromogranin A and neurone-specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer

4. High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment

5. Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortality

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3